Bleakley Financial Group, LLC Karyopharm Therapeutics Inc. Transaction History

Bleakley Financial Group, LLC

  • $3.32 Trillion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
BUY
$0.87 - $1.58 $4,479 - $8,135
5,149 Added 11.7%
49,160 $42.7 Million
Q1 2024

May 08, 2024
BUY
$0.72 - $1.66 $4,372 - $10,081
6,073 Added 16.01%
44,011 $66.5 Million
Q4 2023

Jan 25, 2024
BUY
$0.68 - $1.31 $25,797 - $49,698
37,938 New
37,938 $32.8 Million
Q2 2023

Aug 14, 2023
BUY
$1.79 - $4.59 $28,579 - $73,283
15,966 New
15,966 $28.6 Million

Others Institutions Holding KPTI

# of Institutions
95
Shares Held
56.5M
Call Options Held
258K
Put Options Held
81.2K
View Full List

About Karyopharm Therapeutics Inc.

KPTI Quotes by TradingView
  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $49.5M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Bleakley Financial Group, LLC Portfolio

Follow Bleakley Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bleakley Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bleakley Financial Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email